PetMed Express, Inc. (PETS)
| Market Cap | 80.49M |
| Revenue (ttm) | 270.77M |
| Net Income (ttm) | -2.57M |
| Shares Out | 20.53M |
| EPS (ttm) | -0.13 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | $1.20 (30.61%) |
| Ex-Dividend Date | Aug 11, 2023 |
| Volume | 128,616 |
| Open | 3.980 |
| Previous Close | 3.980 |
| Day's Range | 3.895 - 3.988 |
| 52-Week Range | 2.900 - 10.530 |
| Beta | 0.71 |
| Analysts | Sell |
| Price Target | 3.50 (-10.71%) |
| Earnings Date | Oct 28, 2024 |
About PETS
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthri... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for PETS stock is "Sell." The 12-month stock price forecast is $3.5, which is a decrease of -10.71% from the latest price.
News
PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DELRAY BEACH, Fla., Sept. 27, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS), today announced that on September 27, 2024, PetMeds granted tw...
PetMed Express, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
DELRAY BEACH, Fla., Aug. 21, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS), will participate in the Morgan Stanley 22nd Annual Global Healt...
PetMed Express, Inc. (PETS) Q1 2025 Earnings Call Transcript
PetMed Express, Inc. (NASDAQ:PETS) Q1 2025 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Reed Anderson - Investor Relations, ICR Sandra Campos - Chief Executive Officer & Pr...
PetMed Express, Inc. Announces Appointment of Doug Krulik as Chief Accounting Officer
Krulik Brings More than 20 Years of Leadership Experience in Finance and Accounting Krulik Brings More than 20 Years of Leadership Experience in Finance and Accounting
PetMed Express, Inc. Investors: Company Investigated by the Portnoy Law Firm
Investors can contact the law firm at no cost to learn more about recovering their losses
PetMed Express, Inc. (PETS) Q4 2024 Earnings Call Transcript
PetMed Express, Inc. (NASDAQ:PETS) Q4 2024 Earnings Conference Call June 11, 2024 4:30 PM ET Company Participants John Mills - Investor Relations, ICR Sandra Campos - Chief Executive Officer and Pres...
PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results
DELRAY BEACH, Fla., June 11, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its fourth quarter and f...
PetMed Express, Inc. Announces Strategic Updates to Executive Leadership Team
Caroline Conegliano appointed Chief Operating Officer Umesh Sripad appointed Chief Digital and Technology Officer Company Announces CFO transition DELRAY BEACH, Fla., June 03, 2024 (GLOBE NEWSWIRE) --...
Pets At Home Purrs As FY Profits Meet Updated Guidance
Pets at Home was one of the FTSE 250's best performers on Wednesday, as the retailer announced full-year results in line with January's downgraded guidance.
PetMed Express, Inc. Appoints Carla Dodds as New Chief Marketing Officer
Accomplished executive will lead integrated marketing strategy to accelerate growth Accomplished executive will lead integrated marketing strategy to accelerate growth
PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2024 Earnings Call
DELRAY BEACH, Fla., May 22, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) ("PetMeds"), will hold a conference call on Tuesday, June 11, 202...
PetMed Express, Inc. Announces Appointment of Justin Mennen to Board of Directors
Veteran technology executive brings decades of experience leading digital transformations across large-scale global enterprises Veteran technology executive brings decades of experience leading digita...
PetMed Express, Inc. Names Sandra Campos as new Chief Executive Officer and President
DELRAY BEACH, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. ("PetMeds®" or the “Company”) (NASDAQ: PETS), Your Trusted Pet Health Expert, today announced that the Board of Directors ha...
PetMeds® Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement
Fiscal 2024 3Q Revenue of $65.3 million , an 11% increase compared to last year including PetCareRx results. AutoShip & Save and PetPlus Membership, 52% of total revenue, up from 42% at the same time ...
PetMeds® to Give Away Free Pet Food for a Year to Three Lucky Pet Owners and $1,000 in PetMeds® Credits to Three Local Animal Shelters
The giveaway comes as PetMeds® partners with Hill's Pet Nutrition to make Science Diet available through petmeds.com, starting March 1 The giveaway comes as PetMeds® partners with Hill's Pet Nutrition...
PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
DELRAY BEACH, Fla., Feb. 15, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (“PetMeds®”) (NASDAQ: PETS), received on February 13, 2024, a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq...
PetMed Express, Inc. (PETS) Q3 2024 Earnings Call Transcript
PetMed Express, Inc. (PETS) Q3 2024 Earnings Call Transcript
PetMeds® Announces Selected Preliminary Third Quarter Financial Results
Company to Restate Certain Previously Issued Financial Statements Due to Correction of Errors in Accounting for Tax-Related Entries; Filing of Form 10-Q to be Delayed Company to Restate Certain Previo...
PetMed Express, Inc. Sets Fiscal Third Quarter 2024 Earnings Call
DELRAY BEACH, Fla., Jan. 29, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (Nasdaq: PETS) (the “Company”), Your Trusted Pet Health ExpertTM will hold a conference call on Thursday, February 8, 2024 at...
PetMeds® Announces new Chairman of the Board
DELRAY BEACH, Fla. , Jan. 8, 2024 /PRNewswire/ -- PetMed Express, Inc. ("PetMeds®") (NASDAQ: PETS), Your Trusted Pet Health Expert™, announces the appointment of Leslie C.
Both Pets and Pet Parents Feel the Strain of Separation Anxiety When Apart, According to a New Survey from PetMeds®
As employees continue to return to work at offices, the ping of missing their pets at home has become more pronounced. A PetMeds® survey of 2,000 pet parents uncovered new data that supports the bond ...
Dividend Stocks: Cuts You Could Have Avoided
In response to macroeconomic challenges, numerous companies are reducing expenses to safeguard their earnings, which can sometimes involve reducing or eliminating dividends. This article highlights th...
PetMeds® Announces the Formation of Veterinarian Advisory Board
Veterinary professor and industry luminary, Dr. Lori Teller, will lead the Board as it oversees company initiatives and fosters collaboration within the veterinary community DELRAY BEACH, Fla. , Nov. ...
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of PetMed Express, Inc. (PETS) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of PetMed Express, I...
The Law Offices of Frank R. Cruz Announces Investigation of PetMed Express, Inc. (PETS) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS) on behalf of investors concerning the Compa...